Please login to the form below

Not currently logged in
Email:
Password:

Aesica creates commercial MD role

Appoints Catalent’s Ian Muir to new position

Aesica has named Ian Muir as the company's first commercial managing director, effective February 24.

The contract development and manufacturing (CDMO) firm Aesica said the creation of the role reflects the company's decision to focus on 'core commercial activities'.

Muir's responsibilities will cover manufacture of active pharmaceutical ingredients, formulation development and formulated products, while he will also lead the expansion of the business into new markets, such as China and Japan.

He joins from the CDMO Catalent where he was responsible for the global provision of contract development and manufacturing services for oral dose forms.

Muir's previous experience also includes commercial responsibilities in the US, Australia and Japan.

Aesica's CEO Robert Hardy said: “Ian brings strong commercial business knowledge and has proven experience of delivering growth and will play a pivotal role in driving further business growth for Aesica across API, formulation development and formulated products.”

5th February 2014

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Attigo (part of the Mednet Group)

Inclusion drives innovation. Attigo, a social enterprise, helps pharma and the socially conscious business shape the future by engaging with...

Latest intelligence

Ludovic Helfgott
Novo Nordisk awakens its ‘Sleeping Beauty’
Biopharm emerges from troubled times to hit ‘solid growth’, says executive vice president Ludovic Helfgott...
How will the Tories’ historic win shape the NHS?
Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore the impact of December’s General Election result on 2020 and beyond...
CSR 'Christmas Spirit' 2019
OPEN Health champions CSR over Christmas by giving back to the community and increasing our activities and efforts...

Infographics